Pharmacotherapy for nerve pain
Therapy | Drug class | Drugs | Mechanism of action | Adverse effects |
---|---|---|---|---|
First-line therapy | Calcium channel blockers | Gabapentin | It inhibits α2δ subunit of VGCCs. | Peripheral swelling |
Pregabalin | It inhibits α2δ subunit of VGCCs. | Peripheral swelling and increased bodyweight | ||
TCAs | Amitriptyline | It inhibits the reuptake of serotonin and norepinephrine. | Arrhythmia and suicide risk | |
SNRI | Duloxetine, venlafaxine | These act by inhibiting the reuptake of serotonin and norepinephrine. | Ataxia, hyperhidrosis and hypertension | |
Second-line therapy | Opioids | Tramadol | It acts by binding to opioid receptors. | Seizures and ataxia |
Tapentadol | It inhibits the reuptake of serotonin and norepinephrine. | Seizures and ataxia | ||
Topical treatments | Lidocaine | It acts by binding to sodium channels. | Local erythema, itching and pain | |
Capsaicin | It interacts chemically with sensory neurons for its action. | Pain and itching | ||
Third-line therapy | Strong opioids | Morphine | It acts by binding to opioid receptors. | Dizziness and lethargy |
Neurotoxins | Botulinum toxin | It acts by decreasing the release of acetylcholine. | Pain at injection site |
SNRI: serotonin-norepinephrine reuptake inhibitors; TCAs: tricyclic antidepressants; VGCCs: voltage-gated calcium channels
Our sincere thanks to Paramveer Singh, Shadab Husain and Jamilur Rahman Ansari for editing the language of this manuscript. The authors gratefully acknowledge the contributions of the collaborators and co-workers mentioned in the cited reference. SC, R Kaur, and AG acknowledges K.R. Mangalam University, AW acknowledges Guru Gobind Singh Indraprastha University (GGSIPU). R Kadian gratefully acknowledges the support and cooperation from the Director of Ram Gopal College, Gurugram. MSA gratefully acknowledges the Vice Chancellor and Dean of Pharmacy, Shree Guru Gobind Singh Tricentenary University (SGTU) for their kind cooperation and support.
SC, AW, R Kaur, and AG: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. R Kadian and MSA: Validation, Writing—review & editing, Supervision.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2023.